SavedAdd your journal

Journals / Acta Oncologica Turcica / 2012 / Cilt: 45 Sayı: 1

Metastatic Eccrine Porocarcinoma with Indolent Clinical Course

Klinik Yavaş Seyirli Metastatik Ekrin Porokarsinoma

Umut Demirci
Ayşe Demirci
Şebnem Ayva
Uğur Coşkun
İlker Yazıcı
Meltem Baykara
Mustafa Benekli
Süleyman Büyükberber
Pages
46–48
Publication Date
2012-04-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We have shown that asymptomatic patients in advanced age can be followed-up without treatment even in metastatic disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Eccrine porocarcinoma is a rare malignancy of eccrine sweat glands.
📊
Key Findings & Data:Standart treatment remains unclear.
💡
Conclusion & Impact:We have shown that asymptomatic patients in advanced age can be followed-up without treatment even in metastatic disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ekrin porokarsinom · Malignite · Metastaz

Abstract

Eccrine porocarcinoma is a rare malignancy of eccrine sweat glands. Standart treatment remains unclear. We presented metastatic eccrine porocarcinoma in advanced age that has a long history of a preexisting skin lesion. We have shown that asymptomatic patients in advanced age can be followed-up without treatment even in metastatic disease.

Özet

Ekrin porokarsinoma ekrin ter bezlerinin nadir görülen bir malignitesidir. Standart tedavisi yoktur. Biz burada daha önceden uzun süredir cilt lezyonları olan ileri yaş bir metastatik ekrin porokarsinoma olgusunu sunduk. Özellikle ileri yaş ve asemptomatik hastaların metastatik bile olsa tedavisiz takip edilebileceğini gösterdik.

🔖

Cite This Article

Demirci, U., Demirci, A., Ayva, Ş., Coşkun, U., Yazıcı, İ., Baykara, M., Benekli, M., Büyükberber, S. (2012). Metastatic Eccrine Porocarcinoma with Indolent Clinical Course. Acta Oncologica Turcica, Cilt: 45 Sayı: 1, 46–48. https://doi.org/10.5505/aot.2012.40085

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Brown CW JR, Dy LC. Eccrine porocarcinoma. Dermatol Ther 2008;21:433-8
  2. Affleck AG, Bong JL, Ostroumova MA, Leach IH, Perks AG, Varma S. Ecrine porocarcinoma, Dermatol Online J 2006;12:17
  3. Wick MR, Goellner JR, Wolfe JT 3rd, Su WP Adnexal carcinomas of the skin. I. Eccrine carcinomas. Cancer 1985;56:1147-62
  4. Chang NC, Tsai KB. Ecrine porocarcinoma of the auricle: a case report. Kaohsiung J Med Sci 2009;25:401-4
  5. Attili SK, Evans A, Fleming CJ. Recurrent pigmented ecrine porocarcinoma presenting as carcinoma erysipeloides. Clin Exp Dermatol 2009;34;493-5
  6. Perez-Garcia J, Morales R, Valverde CM, et al. Eccrine porocarcinoma presenting with scrotal lymphedema: a case report and review of systemic treatment. Ann Oncol 2010;21:907
  7. Gutermuth J, Audring H, Voit C, Trefzer U, Haas N, Antitumour activity of paclitaxel and interferon- alpha in a case of metastatic eccrine porocarcinoma. J Eur Acad Dermatol Venereol 2004;18:477-9
  8. Plunkett TA, Hanby AM, Miles DW, Rubens RD, Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapy, Ann Oncol 2001;12:411-4
  9. Piedbois P, Breau JL, Morere JF, Israel L. Sweat gland carcinoma with bone and visceral metastases. Prolonged complete remission lasting 16 months as a result of chemotherapy. Cancer 1987;60:170-2
  10. Coonley CJ, Schauer P, Kelsen DP, Sordillo P, Huvos AG, Chemotherapy of metastatic sweat gland carcinoma. Am J Clin Oncol 1985;8:307-11